Advanced search×

Welcome to the Pubget Medical Subject Headings (MeSH) browser.

Click on a topic or subtopic below to explore related papers. You'll find the most recent paper about the current MeSH term along with other related papers below.

All › Organic Chemicals › Amides › Benzamides

Benzamides (13)

Articles on Benzamides

  1. Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells.
    S-I SI Lee, K-H KH Park, ... E-C EC Kim

    Clin Exp Immunol 168(1):113-24 (2012) PMID 22385246

    These results suggest that MS activates human PDL cells to express immune/defence genes encoding cytokines, chemokines, defensins and TLRs via a SIRT1 pathway. © 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology....
  2. Transcriptional analysis of the Aurora inhibitor Danusertib leading to biomarker identification in TP53 wild type cells.
    Roberta R Bosotti, Patrizia P Carpinelli, ... Antonella A Isacchi

    Gene 494(2):202-8 (2012) PMID 21914463

    We carried out gene expression profiling of wt and TP53 mutant tumor cells showing differential cell cycle response upon drug treatment. We found that treatment with Danusertib induces a strong transcriptional response only in TP53 wt cells, with an overlapping pattern of expression of TP53-dependen...
  3. Novel pathway of centrosome amplification that does not require DNA lesions.
    Masataka M Tsuda, Masakazu M Tanaka, ... Masanao M Miwa

    Cancer Sci 103(2):191-6 (2012) PMID 22085410

    We showed that centrosome amplification could be induced by 3-aminobenzamide (3-AB), an inhibitor of poly(ADP-ribose) polymerases (PARPs) in mouse embryonic fibroblasts. In this paper, we determined if the effect of 3-AB on centrosome amplification was dependent on DNA damage in CHO-K1 cells. We use...
  4. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
    C C Jerome, M M Missbach, and R R Gamse

    Osteoporos Int 23(1):339-49 (2012) PMID 21380636

    Balicatib, an inhibitor of the osteoclastic enzyme cathepsin K, was tested in ovariectomized monkeys, a model for osteoporosis. As expected, ovariectomy-induced bone mass changes were partially prevented by balicatib treatment. Bone turnover was significantly decreased at most sites,...
  5. Ruthenium-catalyzed C-H/N-O bond functionalization: green isoquinolone syntheses in water.
    Lutz Ackermann and Sabine Fenner

    Org Lett 13(24):6548-51 (2011) PMID 22077379

    Ruthenium-catalyzed isoquinolone syntheses with ample scope were accomplished through carboxylate assistance in environmentally benign water as a reaction medium. The high chemoselectivity of the ruthenium(II) carboxylate complex also set the stage for the direct use of free hydroxam...
  6. Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.
    Leisl M LM Packer, Sareena S Rana, ... Richard R Marais

    Cancer Cell 20(6):715-27 (2011) PMID 22169110

    We show that imatinib, nilotinib, and dasatinib possess weak off-target activity against RAF and, therefore, drive paradoxical activation of BRAF and CRAF in a RAS-dependent manner. Critically, because RAS is activated by BCR-ABL, in drug-resistant chronic myeloid leukemia (CML) cells, RAS activity...
  7. [New goals in COPD treatment. From symptom control to prevention of exacerbations].
    Christine C Vetter

    MMW Fortschr Med 153(48):48-9 (2011) PMID 22299261

  8. Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs.
    Jun-ichi J Eiki, Yasufumi Y Nagata, ... Joel P JP Berger

    Mol Pharmacol 80(6):1156-65 (2011) PMID 21937665

    We report key pharmacokinetic and pharmacodynamic findings from preclinical studies of the GKA 3-[[6-(ethylsulfonyl)-3-pyridinyl]oxy]-5-[(1S)-2-hydroxy-1-methylethoxy]-N-(1-methyl-1H-pyrazol-3-yl)benzamide (MK-0941). Incubated in vitro with recombinant human glucokinase, 1 μM MK-0941 lowered the S(...
  9. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
    San-Cher SC Chen, Jinn-Yuh JY Guh, ... Lea-Yea LY Chuang

    Transl Res 158(4):214-24 (2011) PMID 21925118

    We studied the effects and molecular mechanisms of gefitinib in TGF-β1-induced mitogenesis and collagen production in normal rat kidney interstitial fibroblast (NRK-49F) cells. We found that TGF-β1 increased cell mitogenesis. TGF-β1 also time-dependently increased cyclin D1 protein expression. TG...
  10. Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.
    Hidetaka H Shibata, Satoshi S Miuma, ... Kay K Huebner

    Cancer Sci 102(10):1882-8 (2011) PMID 21707865

    When DNA damage is detected, checkpoint signal networks are activated to stop the cell cycle, and DNA repair processes begin. Inhibitory compounds targeting components of DNA damage response pathways have been identified and are being used in clinical trials, in combination with chem...
    View PDF